The US Food and Drug Administration has granted breakthrough therapy designation to Oculis’ neuroprotective candidate ...

Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...

CHEYENNE, WY / ACCESS Newswire / June 9, 2025 / Row64, creators of the only visual real-time business intelligence platform for big data, today announced its $4 million seed funding round led by ...

Jubileye Health Dry Eye & Glare Defense represents a breakthrough in ocular wellness, built on cutting-edge research and clinically studied ingredients that target the root causes of eye discomfort.

DOWNERS GROVE, Ill., Oct. 19, 2023 /PRNewswire/ -- CDS Visual, part of Dover (NYSE: DOV) and a leading provider of software as a service (SaaS) 3D visualization solutions, today announced the release ...